ADBiotech Co., Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was KRW 0.00043 million compared to KRW 0.00005 million a year ago. Net income was KRW 2,696.28 million compared to net loss of KRW 2,664.47 million a year ago.

Basic earnings per share from continuing operations was KRW 297 compared to basic loss per share from continuing operations of KRW 347 a year ago. Diluted earnings per share from continuing operations was KRW 119 compared to diluted loss per share from continuing operations of KRW 347 a year ago. Basic earnings per share was KRW 297 compared to basic loss per share of KRW 347 a year ago.

Diluted earnings per share was KRW 119.